BG106914A - Microcapsules containing functionalized polyalkylcyanoacrylates - Google Patents

Microcapsules containing functionalized polyalkylcyanoacrylates

Info

Publication number
BG106914A
BG106914A BG106914A BG10691402A BG106914A BG 106914 A BG106914 A BG 106914A BG 106914 A BG106914 A BG 106914A BG 10691402 A BG10691402 A BG 10691402A BG 106914 A BG106914 A BG 106914A
Authority
BG
Bulgaria
Prior art keywords
microcapsules containing
containing functionalized
polyalkylcyanoacrylates
microcapsules
functionalized polyalkylcyanoacrylates
Prior art date
Application number
BG106914A
Other languages
Bulgarian (bg)
English (en)
Inventor
Barry Potter
Michael Reed
Walter Elger
Gudrun Roddesen
Henrich-Thomas Proske
Original Assignee
Sterix Limited
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0000792A external-priority patent/GB0000792D0/en
Priority claimed from GB0002115A external-priority patent/GB0002115D0/en
Application filed by Sterix Limited, Schering Aktiengesellschaft filed Critical Sterix Limited
Publication of BG106914A publication Critical patent/BG106914A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Confectionery (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
BG106914A 2000-01-14 2002-07-11 Microcapsules containing functionalized polyalkylcyanoacrylates BG106914A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0000792A GB0000792D0 (en) 2000-01-14 2000-01-14 Composition
GB0002115A GB0002115D0 (en) 2000-01-28 2000-01-28 Composition
US21873000P 2000-07-17 2000-07-17
PCT/GB2001/000094 WO2001051055A2 (en) 2000-01-14 2001-01-11 Pharmaceutical compositions containing steroidal structures and uses thereof

Publications (1)

Publication Number Publication Date
BG106914A true BG106914A (en) 2003-01-31

Family

ID=27255470

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106914A BG106914A (en) 2000-01-14 2002-07-11 Microcapsules containing functionalized polyalkylcyanoacrylates

Country Status (26)

Country Link
EP (1) EP1248626B1 (de)
JP (1) JP2003519658A (de)
KR (1) KR20020087930A (de)
CN (1) CN1404394A (de)
AR (1) AR028196A1 (de)
AT (1) ATE332140T1 (de)
AU (1) AU2533101A (de)
BG (1) BG106914A (de)
BR (1) BR0107630A (de)
CA (1) CA2396098A1 (de)
CO (1) CO5280199A1 (de)
CZ (1) CZ20022282A3 (de)
DE (1) DE60121293T2 (de)
EE (1) EE200200391A (de)
ES (1) ES2267707T3 (de)
HR (1) HRP20020665A2 (de)
HU (1) HUP0300887A2 (de)
IL (1) IL150471A0 (de)
MX (1) MXPA01000464A (de)
NO (1) NO20023392L (de)
PE (1) PE20011121A1 (de)
PL (1) PL357020A1 (de)
SK (1) SK10022002A3 (de)
TR (1) TR200100070A3 (de)
UY (1) UY26530A1 (de)
WO (1) WO2001051055A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
EP1358882A1 (de) * 2002-04-30 2003-11-05 Schering Aktiengesellschaft Verwendung von Prodrogue von Estriol sulfamate zur Behandlung von autoimmunischen Erkrankungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
KR200449618Y1 (ko) * 2008-01-16 2010-07-23 주식회사 코비스 스포츠 그린보수기
GB201302368D0 (en) * 2013-02-11 2013-03-27 Univ Bath Compound
EP4098264A1 (de) * 2017-06-01 2022-12-07 Nexyon Biotech Co., Ltd. Pharmazeutische zusammensetzung zur prävention oder behandlung von knochenerkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen

Also Published As

Publication number Publication date
UY26530A1 (es) 2001-07-31
CZ20022282A3 (cs) 2002-11-13
ATE332140T1 (de) 2006-07-15
EE200200391A (et) 2003-12-15
IL150471A0 (en) 2002-12-01
ES2267707T3 (es) 2007-03-16
DE60121293D1 (de) 2006-08-17
JP2003519658A (ja) 2003-06-24
AU2533101A (en) 2001-07-24
KR20020087930A (ko) 2002-11-23
WO2001051055A2 (en) 2001-07-19
MXPA01000464A (es) 2003-07-21
BR0107630A (pt) 2002-10-08
TR200100070A2 (tr) 2001-08-21
NO20023392L (no) 2002-09-16
HRP20020665A2 (en) 2004-12-31
DE60121293T2 (de) 2007-06-28
CO5280199A1 (es) 2003-05-30
AR028196A1 (es) 2003-04-30
CA2396098A1 (en) 2001-07-19
NO20023392D0 (no) 2002-07-12
TR200100070A3 (tr) 2001-08-21
PE20011121A1 (es) 2001-11-05
SK10022002A3 (sk) 2002-12-03
EP1248626A2 (de) 2002-10-16
WO2001051055A3 (en) 2002-03-21
HUP0300887A2 (hu) 2003-07-28
CN1404394A (zh) 2003-03-19
PL357020A1 (en) 2004-07-12
EP1248626B1 (de) 2006-07-05

Similar Documents

Publication Publication Date Title
YU68902A (sh) Mikrokapsule koje podrazumevaju funkcionalizovane polialkilcijanoakrilate
PL366081A1 (en) Polysiloxane polymers, method for their production and the use thereof
EP1180371A4 (de) WIRKSTOFFE ZUR FöRDERUNG DER AUSBILDUNG EINER MEMBRAN ALS HAUTGRUNDLAGE, WIRKSTOFFE ZUR FöRDERUNG DER AUSBILDUNG VON KüNSTLICHER HAUT UND VERFAHREN ZUR HERSTELLUNG VON KüNSTLICHER HAUT
DE602004011497D1 (de) Symbiotische zusammensetzung
ATE545668T1 (de) Klebstoffe
WO2005047471A3 (en) Improved fret efficiency methods
BG106914A (en) Microcapsules containing functionalized polyalkylcyanoacrylates
MXPA04002052A (es) Tela para proceso industrial.
WO2002068465A3 (en) Novel p53-inducible protein
WO2005028058A3 (en) Linkable-shared friendship objects
NO20003146D0 (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
BG104608A (en) Method for producing polyamides from aminonitriles
AU2003233579A8 (en) Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
AU2003268970A8 (en) Aqueous polymer dispersion, preparation and use thereof
CA104209S (en) Snack piece
TW200503096A (en) Cleaning member and cleaning method
CA116164S (en) Snack piece
MXPA04005513A (es) Nuevas fitasas y procedimiento de produccion de estas fitasas.
HUP0104787A3 (en) Modification agents for anionic polymerisation and use thereof, as well as the produced polymers and use thereof
ATE373101T1 (de) Gene, die im zusammenhang mit der biosynthese von ml-236b stehen
AU2002235773A1 (en) Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
GB2380484B (en) Chain extended functionalized initiators and methods of preparing and using the same
ATE272663T1 (de) Polymere
WO2025179182A3 (en) C3 targeted inhibitory rna
GR970100071A (el) Συστημα παραγωγης λευκης ζαχαρης βασιζομενο σε μια νεα μεθοδο παραγωγης και ταυτοχρονα στην προυπαρχουσα τεχνολογια